What Our Prescribers Say

It’s powerful when respected opinion leaders in ophthalmology and optometry render supportive verdicts about our compounded medications. Especially when it’s based on first-hand experience.

Physician Testimonial

Physician Testimonial

Physician Testimonial


What Patients Say

Patient experience is at the heart of OSRX. It’s why our pharmacists and technicians are always just a phone call away, why we compound multiple medications into a single dose to simplify eye care and why we offer affordable, transparent prices.

Here's what actual patients had to say about our compounded medications, prices and service in March 2022 surveys.*

What Our Patients Say
What Our Patients Say

 

“OSRX has been a pleasure to work with. We’ve been extremely happy with their compounded OMNI drops and use them exclusively for cataract surgery, LASIK and other procedures. Their bottles are easier to use than other pharmacy’s products, cost is minimal, and their customer service is second to none.”
- DR. DAVID TREMBLAY, MD, MANN EYE INSTITUTE AND LASER CENTER

“From a patient satisfaction standpoint, I can tell you without hesitation that patients are much happier with these products and our new level of service.”1
- JONATHAN D. SOLOMON, MD, SOLOMON EYE PHYSICIANS & SURGEONS

“From the very beginning of our relationship with OSRX, their team has provided top-notch customer service to our staff and patients. Their products are affordable for our patients and provide them with an easy, all-in-one system to use for their pre/post-operative treatment.  In addition, their continued support and follow through is exceptional.”
- ANGIE RIDGE, DIRECTOR OF SURGERY COUNSELING, JOHN-KENYON EYE CENTERS

“… patients in my practice overwhelmingly preferred the convenience and decreased cost of a single drop.”3
- NICOLE FRAM, MD, ADVANCED VISION CARE

“It is very convenient that patients have to only use one bottle of medications for surgery. It has eliminated any confusion on the patient's end and decreased chair time during post-op evaluations. I am very pleased with the compounded eye drops that we order through OSRX."
- MICHAEL ROM, MD, INSIGHT EYE CENTER

Drs. Tauber, Gupta and Melendez are current or former medical advisory board members for Ocular Science® (an OSRX affiliate) and have a financial interest in the company.

*Data according to OSRX patient satisfaction surveys, March 2022.

1,2,3: MillennialEYE, 2017 Innovations: "A New Approach to Compounded Ophthalmic Therapies"

OSRX operates in full compliance with Section 503A regarding compounded drugs as defined in the FD&C Act.

*Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality. 503A compounding pharmacies are not required to comply with cGMP requirements but can be inspected by FDA. References available upon request.

Click here to view potential contraindications.